Chemours (CC) Other Accumulated Expenses (2015 - 2026)

Chemours' Other Accumulated Expenses history runs 12 years deep, the most recent figure standing at $97.0 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 3.0% year-over-year to $97.0 million; the TTM figure through Mar 2026 stood at $97.0 million (down 3.0% YoY), while the FY2025 annual figure was $150.0 million, up 36.36% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $97.0 million, down from $150.0 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $239.0 million in Q2 2022, with the low at $74.0 million in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $129.0 million (2023), against an average of $137.5 million.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses soared 187.67% in 2022, then slumped 40.48% in 2023.
• Chemours' Other Accumulated Expenses stood at $74.0 million in 2022, then soared by 74.32% to $129.0 million in 2023, then decreased by 14.73% to $110.0 million in 2024, then soared by 36.36% to $150.0 million in 2025, then slumped by 35.33% to $97.0 million in 2026.
• Business Quant data shows CC's Other Accumulated Expenses at $97.0 million in Q1 2026, $150.0 million in Q4 2025, and $107.0 million in Q3 2025.